The DOI matches its Crossref record; 64 of the 64 references it cites were found in a registry or an index.
Risk Alleles for Multiple Sclerosis Identified by a Genomewide Study
Abstract
Background Multiple sclerosis has a clinically significant heritable component. We conducted a genomewide association study to identify alleles associated with the risk of multiple sclerosis. Methods We used DNA microarray technology to identify common DNA sequence variants in 931 family trios (consisting of an affected child and both parents) and tested them for association. For replication, we genotyped another 609 family trios, 2322 case subjects, and 789 control subjects and used genotyping data from two external control data sets. A joint analysis of data from 12,360 subjects was performed to estimate the overall significance and effect size of associations between alleles and the risk of multiple sclerosis. Results A transmission disequilibrium test of 334,923 single-nucleotide polymorphisms (SNPs) in 931 family trios revealed 49 SNPs having an association with multiple sclerosis (P Conclusions Alleles of IL2RA and IL7RA and those in the HLA locus are identified as heritable risk factors for multiple sclerosis.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“In 2007, the first GWAS in MS looked at 1540 parent‐affected offspring trios and identified two loci outside the MHC, encoding the interleukin‐2 receptor (IL‐2RA) and the interleukin‐7 receptor (IL‐7RA), respectively.30”
From Genome‐wide association studies of multiple sclerosis (2018) · cites this paper as [30]
In the citing paper
“These validated the HLA association but showed no significant linkage to loci outside the MHC.”
From Genome‐wide association studies of multiple sclerosis (2018) · cites this paper as [30]
Citations
Cites
McDonald, W. I., Compston, A., Edan, G., Goodkin, D., Hartung, H., Lublin, F. D., McFarland, H. F., Paty, D. W., Polman, C. H., Reingold, S. C., et al. (2001) · Annals of Neurology · doi:10.1002/ana.1032 · Cited by 6,969
A haplotype map of the human genome
The International HapMap Consortium (2005) · Nature · doi:10.1038/nature04226 · Cited by 5,858
Self-citationThe Future of Genetic Studies of Complex Human Diseases
Risch, N., & Merikangas, K. (1996) · Science · doi:10.1126/science.273.5281.1516 · Cited by 5,355
Diagnostic criteria for multiple sclerosis: 2005 revisions to the “McDonald Criteria”
Polman, C. H., Reingold, S. C., Edan, G., Filippi, M., Hartung, H., Kappos, L., Lublin, F. D., Metz, L. M., McFarland, H. F., O'Connor, P. W., et al. (2005) · Annals of Neurology · doi:10.1002/ana.20703 · Cited by 5,017
Axonal transection in the lesions of multiple sclerosis
Trapp, B. D., Peterson, J., Ransohoff, R. M., Rudick, R., Mörk, S., & Bö, L. (1998) · New England Journal of Medicine · doi:10.1056/nejm199801293380502 · Cited by 4,029
A Genome-Wide Association Study Identifies IL23R as an Inflammatory Bowel Disease Gene
Duerr, R. H., Taylor, K. D., Brant, S. R., Rioux, J. D., Silverberg, M. S., Daly, M. J., Steinhart, A. H., Abraham, C., Regueiro, M., Griffiths, A., et al. (2006) · Science · doi:10.1126/science.1135245 · Cited by 3,039
A genome-wide association study identifies novel risk loci for type 2 diabetes
Sladek, R., Rocheleau, G., Rung, J., Dina, C., Shen, L., Serre, D., Boutin, P., Vincent, D., Belisle, A., Hadjadj, S., et al. (2007) · Nature · doi:10.1038/nature05616 · Cited by 2,993
Genome-wide association analysis identifies loci for type 2 diabetes and triglyceride levels
Saxena, R., Voight, B. F., Lyssenko, V., Burtt, N. P., de Bakker, P. I. W., Chen, H., Roix, J. J., Kathiresan, S., Hirschhorn, J. N., Daly, M. J., et al. (2007) · Science · doi:10.1126/science.1142358 · Cited by 2,843
A genome-wide association study of type 2 diabetes in Finns detects multiple susceptibility variants
Scott, L. J., Mohlke, K. L., Bonnycastle, L. L., Willer, C. J., Li, Y., Duren, W. L., Erdos, M. R., Stringham, H. M., Chines, P. S., Jackson, A. U., et al. (2007) · Science · doi:10.1126/science.1142382 · Cited by 2,753
Revised diagnostic criteria for neuromyelitis optica
Wingerchuk, D. M., Lennon, V. A., Pittock, S. J., Lucchinetti, C. F., & Weinshenker, B. G. (2006) · Neurology · doi:10.1212/01.wnl.0000216139.44259.74 · Cited by 2,568
Research works printed but not linked: 1
- Prineas JW, 1978, Lab Invest, 38, 409
Cited by
Sorted by citations
Items 501–600 of 1,000
Evsyukova, I. Y., Bradrick, S. S., Gregory, S. G., & García-Blanco, M. A. (2012) · RNA · doi:10.1261/rna.035410.112 · Cited by 51
Ahlgren, C., Torén, K., Odén, A., & Andersen, O. (2009) · European Journal of Epidemiology · doi:10.1007/s10654-009-9367-2 · Cited by 47
Therapies for multiple sclerosis: considerations in the pediatric patient
Banwell, B., Bar‐Or, A., Giovannoni, G., Dale, R. C., & Tardieu, M. (2011) · Nature Reviews Neurology · doi:10.1038/nrneurol.2010.198 · Cited by 46
Insight from genome‐wide association studies in rheumatoid arthritis and multiple sclerosis
Suzuki, A., Kochi, Y., Okada, Y., & Yamamoto, K. (2011) · FEBS Letters · doi:10.1016/j.febslet.2011.05.025 · Cited by 45
Genetic determinants of risk and progression in multiple sclerosis
Didonna, A., & Oksenberg, J. R. (2015) · Clinica Chimica Acta · doi:10.1016/j.cca.2015.01.034 · Cited by 49
Menon, R., Dario, M. D., Cordiglieri, C., Musio, S., Mantia, L. L., Milanese, C., Stefano, A. L. D., Crabbio, M., Franciotta, D. M., Bergamaschi, R., et al. (2011) · Journal of Autoimmunity · doi:10.1016/j.jaut.2011.11.004 · Cited by 46
Multiple sclerosis incidence in the era of measles-mumps-rubella mass vaccinations
Ahlgren, C., Odén, A., Torén, K., & Andersen, O. (2008) · Acta Neurologica Scandinavica · doi:10.1111/j.1600-0404.2008.01131.x · Cited by 45
Decreased systemic IL-7 and soluble IL-7Rα in multiple sclerosis patients
Kreft, K. L., Verbraak, E., Wierenga‐Wolf, A. F., van Meurs, M., Oostra, B. A., Laman, J. D., & Hintzen, R. Q. (2012) · Genes and Immunity · doi:10.1038/gene.2012.34 · Cited by 46
Buck, D., Albrecht, E., Aslam, M., Goris, A., Hauenstein, N., Jochim, A., Cepok, S., Grummel, V., Dubois, B., Berthele, A., et al. (2012) · Annals of Neurology · doi:10.1002/ana.23749 · Cited by 48
The human lexinome: Genes of language and reading
Gibson, C. J., & Gruen, J. R. (2008) · Journal of Communication Disorders · doi:10.1016/j.jcomdis.2008.03.003 · Cited by 48
Genome-Wide Association Study of Multiple Sclerosis Confirms a Novel Locus at 5p13.1
Matesanz, F., González‐Pérez, A., Lucas, M., Sanna, S., Gayán, J., Urcelay, E., Zara, I., Pitzalis, M., Cavanillas, M. L., Arroyo, R., et al. (2012) · PLoS ONE · doi:10.1371/journal.pone.0036140 · Cited by 45
Genome-wide association study identifies MAPT locus influencing human plasma tau levels
Chen, J., Yu, J., Wojta, K. J., Wang, H.-F., Zetterberg, H., Blennow, K., Yokoyama, J. S., Weiner, M. W., Kramer, J. H., Rosen, H. J., et al. (2017) · Neurology · doi:10.1212/wnl.0000000000003615 · Cited by 46
Cell Type-Specific Intralocus Interactions Reveal Oligodendrocyte Mechanisms in MS
Factor, D. C., Barbeau, A. M., Allan, K. C., Hu, L. R., Madhavan, M., Hoang, A. T., Hazel, K. E. A., Hall, P. A., Nisraiyya, S., Najm, F. J., et al. (2020) · Cell · doi:10.1016/j.cell.2020.03.002 · Cited by 48
Rafiq, S., Melzer, D. R., Weedon, M. N., Lango, H., Saxena, R., Scott, L. J., Palmer, C. N. A., Morris, A. D., McCarthy, M. I., Ferrucci, L., et al. (2008) · Diabetologia · doi:10.1007/s00125-008-1160-3 · Cited by 47
Liu, G., Zhang, F., Jiang, Y., Hu, Y., Gong, Z., Liu, S., Chen, X., Jiang, Q., & Hao, J. (2016) · Multiple Sclerosis Journal · doi:10.1177/1352458516649038 · Cited by 45
No evidence of association between mutant alleles of the CYP27B1 gene and multiple sclerosis
Ban, M., Caillier, S. J., Mero, I., Myhr, K., Celius, E. G., Aarseth, J. H., Torkildsen, Ø., Harbo, H. F., Oksenberg, J. R., Hauser, S. L., et al. (2012) · Annals of Neurology · doi:10.1002/ana.23833 · Cited by 45
Wang, H., Zhong, X., Wang, K., Qiu, W., Li, J., Dai, Y., & Hu, X. (2011) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2011.11.005 · Cited by 45
From Identification to Characterization of the Multiple Sclerosis Susceptibility Gene CLEC16A
Berge, T., Leikfoss, I., & Harbo, H. (2013) · International Journal of Molecular Sciences · doi:10.3390/ijms14034476 · Cited by 45
Ellis, J., van Maurik, A., Fortunato, L., Gisbert, S., Chen, K., Schwartz, A. M., McHugh, S. M., Want, A., Franco, S. S., Oliveira, J., et al. (2018) · British Journal of Clinical Pharmacology · doi:10.1111/bcp.13748 · Cited by 45
Deconstructing and targeting the genomic architecture of human neurodegeneration
Jager, P. L. D., Yang, H., & Bennett, D. A. (2018) · Nature Neuroscience · doi:10.1038/s41593-018-0240-z · Cited by 46
Strategies for Neuroprotection in Multiple Sclerosis and the Role of Calcium
Enders, M., Heider, T., Ludwig, A., & Küerten, S. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21051663 · Cited by 45
Variants in several genomic regions associated with asperger disorder
Salyakina, D., Ma, D. Q., Jaworski, J. M., Konidari, I., Whitehead, P. L., Henson, R., Martinez, D. M., Robinson, J. L., Sacharow, S. J., Wright, H. H., et al. (2010) · Autism Research · doi:10.1002/aur.158 · Cited by 44
Mero, I.-L., Ban, M., Lorentzen, Å. R., Smestad, C., Celius, E. G., Sæther, H. S., Saeedi, H., Viken, M. K., Skinningsrud, B., Undlien, D. E., et al. (2010) · Genes and Immunity · doi:10.1038/gene.2010.59 · Cited by 44
Replication of KIF21B as a susceptibility locus for multiple sclerosis: Table 1
Goris, A., Boonen, S., D'hooghe, M. B., & Dubois, B. (2010) · Journal of Medical Genetics · doi:10.1136/jmg.2009.075911 · Cited by 43
Epstein-barr virus in multiple sclerosis
Bagert, B. A. (2009) · Current Neurology and Neuroscience Reports · doi:10.1007/s11910-009-0059-9 · Cited by 43
Pathogenic mechanisms and experimental models of multiple sclerosis
Slavin, A., Modis, L. K., Labadia, M. E., Ryan, K. R., & Brown, M. L. (2010) · Autoimmunity · doi:10.3109/08916931003674733 · Cited by 45
A Sardinian Map for Multiple Sclerosis
Cossu, D., Masala, S., & Sechi, L. A. (2013) · Future Microbiology · doi:10.2217/fmb.12.135 · Cited by 45
Multiple sclerosis associates with LILRA3 deletion in Spanish patients
Ordóñez, D., Sánchez, A., Rodríguez, J., Cisneros, E., Ramil, E., Romo, N., Moraru, M., Munteis, E., López‐Botet, M., Roquer, J., et al. (2009) · Genes and Immunity · doi:10.1038/gene.2009.34 · Cited by 45
Libbey, J. E., & Fujinami, R. S. (2009) · Results and problems in cell differentiation · doi:10.1007/400_2008_12 · Cited by 45
Expression analysis and functional activity of interleukin-7 splice variants
Vudattu, N. K., Magalhaes, I., Hoehn, H., Pan, D., & Maeurer, M. J. (2008) · Genes and Immunity · doi:10.1038/gene.2008.90 · Cited by 46
Study of the association between the CAPSL-IL7R locus and type 1 diabetes
Santiago, J. L., Alizadeh, B. Z., Martínez, A., Espino‐Paisán, L., de la Calle, H., Fernández‐Arquero, M., Figueredo, M. A., de la Concha, E. G., Roep, B. O., Koeleman, B. P. C., et al. (2008) · Diabetologia · doi:10.1007/s00125-008-1070-4 · Cited by 44
Variation Within DNA Repair Pathway Genes and Risk of Multiple Sclerosis
Briggs, F. B. S., Goldstein, B. A., McCauley, J. L., Zuvich, R. L., Jager, P. L. D., Rioux, J. D., Ivinson, A. J., Compston, A., Hafler, D. A., Hauser, S. L., et al. (2010) · American Journal of Epidemiology · doi:10.1093/aje/kwq086 · Cited by 43
Mukherjee, S., Russell, J. C., Carr, D. T., Burgess, J. D., Allen, M., Serie, D. J., Boehme, K. L., Kauwe, J. S. K., Naj, A. C., Fardo, D. W., et al. (2017) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2017.01.016 · Cited by 39
Haas, J., Korporal, M., Schwarz, A., Balint, B., & Wildemann, B. (2010) · European Journal of Immunology · doi:10.1002/eji.201041139 · Cited by 44
Perez‐Nievas, B. G., García‐Bueno, B., Madrigal, J. L. M., & Leza, J. C. (2010) · Journal of Neuroinflammation · doi:10.1186/1742-2094-7-60 · Cited by 43
The Genetics of Juvenile Idiopathic Arthritis: What Is New in 2010?
Angeles‐Han, S. T., & Prahalad, S. (2010) · Current Rheumatology Reports · doi:10.1007/s11926-010-0087-0 · Cited by 43
Role of dimethyl fumarate in oxidative stress of multiple sclerosis: A review
Suneetha, A., & Rajeswari, K. R. (2016) · Journal of Chromatography B · doi:10.1016/j.jchromb.2016.02.010 · Cited by 46
Ostrowski, J., Paziewska, A., Łazowska‐Przeorek, I., Ambrożkiewicz, F., Goryca, K., Kulecka, M., Rawa, T., Karczmarski, J., Dąbrowska, M., Żeber‐Lubecka, N., et al. (2016) · Scientific Reports · doi:10.1038/srep39831 · Cited by 43
Investigation of common, low-frequency and rare genome-wide variation in anorexia nervosa
Huckins, L. M., Hatzikotoulas, K., Southam, L., Thornton, L. M., Steinberg, J., Aguilera-McKay, F., Treasure, J. L., Schmidt, U., Gunasinghe, C., Romero, A., et al. (2017) · Molecular Psychiatry · doi:10.1038/mp.2017.88 · Cited by 44
Anti-heart autoantibodies in familial dilated cardiomyopathy
Caforio, A. L. P., Vinci, A., & Iliceto, S. (2008) · Autoimmunity · doi:10.1080/08916930802031546 · Cited by 44
Multiple Sclerosis and Autoimmunity: A Veiled Relationship
Barkhane, Z., Elmadi, J., Kumar, L. S., Pugalenthi, L. S., Ahmad, M., & Reddy, S. (2022) · Cureus · doi:10.7759/cureus.24294 · Cited by 44
Redler, S., Albert, F., Brockschmidt, F. F., Herold, C., Hanneken, S., Eigelshoven, S., Giehl, K. A., Kruse, R., Lutz, G., Wolff, H., et al. (2012) · British Journal of Dermatology · doi:10.1111/bjd.12004 · Cited by 42
Radandish, M., Khalilian, P., & Esmaeil, N. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.667705 · Cited by 41
Zivadinov, R., Weinstock‐Guttman, B., Zorzon, M., Uxa, L., Serafin, M., Bosco, A., Bratina, A., Maggiore, C., Grop, A., Tommasi, M. A., et al. (2009) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2009.01.023 · Cited by 42
Refining the association of MHC with multiple sclerosis in African Americans
McElroy, J. P., Cree, B., Caillier, S. J., Gregersen, P. K., Herbert, J., Khan, O. A., Freudenberg, J., Lee, A., Bridges, S. L., Hauser, S. L., et al. (2010) · Human Molecular Genetics · doi:10.1093/hmg/ddq197 · Cited by 41
Risk Alleles for Multiple Sclerosis Identified by a Genomewide Study
Verma, A. (2008) · Yearbook of Neurology and Neurosurgery · doi:10.1016/s0513-5117(08)79017-3 · Cited by 42
Daclizumab (anti-CD25) in multiple sclerosis
Pfender, N., & Martinꝉ, R. (2014) · Experimental Neurology · doi:10.1016/j.expneurol.2014.04.015 · Cited by 44
IL7RA polymorphisms and chronic inflammatory arthropathies
O’Doherty, C., Alloza, I., Rooney, M., & Vandenbroeck, K. (2009) · Tissue Antigens · doi:10.1111/j.1399-0039.2009.01342.x · Cited by 42
Vandenbroeck, K., Alloza, I., Swaminathan, B., Antigüedad, A. R., Otaegui, D., Olascoaga, J., Barcina, M. G., Heras, V. D. L., Bartolomé, M., Fernández‐Arquero, M., et al. (2010) · Genes and Immunity · doi:10.1038/gene.2010.46 · Cited by 41
Mastorodemos, V. C., Ιωάννου, Μ., & Verginis, P. (2014) · NeuroImmunoModulation · doi:10.1159/000362370 · Cited by 41
Buzzard, K. A., Broadley, S., & Butzkueven, H. (2012) · International Journal of Molecular Sciences · doi:10.3390/ijms131012665 · Cited by 51
Treating multiple sclerosis with monoclonal antibodies
Buttmann, M., & Rieckmann, P. (2008) · Expert Review of Neurotherapeutics · doi:10.1586/14737175.8.3.433 · Cited by 41
Lipoprotein markers associated with disability from multiple sclerosis
Gafson, A. R., Thorne, T., McKechnie, C. I. J., Jimenez, B., Nicholas, R., & Matthews, P. M. (2018) · Scientific Reports · doi:10.1038/s41598-018-35232-7 · Cited by 40
The IL-2 – IL-2 receptor pathway: Key to understanding multiple sclerosis
Peerlings, D. E. M., Mimpen, M., & Damoiseaux, J. G. M. C. (2021) · Journal of Translational Autoimmunity · doi:10.1016/j.jtauto.2021.100123 · Cited by 45
Li, R., Li, H., Yang, X., Hu, H., Liu, P., & Liu, H. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.970508 · Cited by 42
Replication of top markers of a genome-wide association study in multiple sclerosis in Spain
Cavanillas, M. L., Fernández, Ó., Comabella, M., Alcina, A., Fedetz, M., Izquierdo, G., Lucas, M., Cénit, M. C., Arroyo, R., Vandenbroeck, K., et al. (2010) · Genes and Immunity · doi:10.1038/gene.2010.52 · Cited by 40
Kuerten, S., & Angelov, D. N. (2008) · Annals of Anatomy - Anatomischer Anzeiger · doi:10.1016/j.aanat.2007.11.001 · Cited by 40
Leikfoss, I. S., Mero, I.-L., Dahle, M. K., Lie, B. A., Harbo, H. F., Spurkland, A., & Berge, T. (2012) · Genes and Immunity · doi:10.1038/gene.2012.52 · Cited by 40
Genetic burden in multiple sclerosis families
Isobe, N., Damotte, V., Re, V. L., Ban, M., Pappas, D. J., Guillot‐Noël, L., Cournu‐Rebeix, I., Compston, A., Mack, T. M., Cozen, W., et al. (2013) · Genes and Immunity · doi:10.1038/gene.2013.37 · Cited by 38
Ban, Y., Tozaki, T., Taniyama, M., Nakano, Y., Ban, Y., Ban, Y., & Hirano, T. (2010) · Thyroid · doi:10.1089/thy.2010.0104 · Cited by 39
The Genetics of Multiple Sclerosis
Didonna, A., & Oksenberg, J. R. (2017) · Codon Publications eBooks · doi:10.15586/codon.multiplesclerosis.2017.ch1 · Cited by 44
Interleukin-7 is required for CD4 + T cell activation and autoimmune neuroinflammation
Lawson, B. R., González‐Quintial, R., Eleftheriadis, T., Farrar, M. A., Miller, S. D., Sauer, K., McGavern, D. B., Kono, D. H., Baccalà, R., & Theofilopoulos, A. N. (2015) · Clinical Immunology · doi:10.1016/j.clim.2015.08.007 · Cited by 41
Opposing functions of IL-2 and IL-7 in the regulation of immune responses
Katzman, S. D., Hoyer, K. K., Dooms, H., Gratz, I. K., Rosenblum, M. D., Paw, J. S., Osum, S. H., & Abbas, A. K. (2011) · Cytokine · doi:10.1016/j.cyto.2011.07.005 · Cited by 41
Immunologic Aspects of Multiple Sclerosis
Boppana, S., Huang, H., Ito, K., & Dhib-Jalbut, S. S. (2011) · Mount Sinai Journal of Medicine A Journal of Translational and Personalized Medicine · doi:10.1002/msj.20249 · Cited by 40
Genetic association analysis: a primer on how it works, its strengths and its weaknesses
Rodriguez‐Murillo, L., & Greenberg, D. A. (2008) · International Journal of Andrology · doi:10.1111/j.1365-2605.2008.00896.x · Cited by 41
Old Suspects Found Guilty — The First Genome Profile of Multiple Sclerosis
Peltonen, L. (2007) · New England Journal of Medicine · doi:10.1056/nejme078147 · Cited by 40
Caron, B., Patin, É., Rotival, M., Charbit, B., Albert, M. L., Quintana‐Murci, L., Duffy, D., Rausell, A., Abel, L., Alcover, A., et al. (2022) · Genome Medicine · doi:10.1186/s13073-022-01032-y · Cited by 43
Menon, R., & Farina, C. (2011) · PLoS ONE · doi:10.1371/journal.pone.0018660 · Cited by 39
Zaunders, J., Lévy, Y., & Seddiki, N. (2014) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2014.07.012 · Cited by 39
Gender Disparities in Ocular Inflammatory Disorders*
Sen, H. N., Davis, J. L., Uçar, D., Fox, A. R., Chan, C. C., & Goldstein, D. A. (2014) · Current Eye Research · doi:10.3109/02713683.2014.932388 · Cited by 41
Thewissen, K., Nuyts, A. H., Deckx, N., Wijmeersch, B. V., Nagels, G., D'hooghe, M. B., Willekens, B. M. P., Cras, P. P., Eijnde, B. O., Goossens, H., et al. (2013) · Multiple Sclerosis Journal · doi:10.1177/1352458513505352 · Cited by 39
Downes, K., Marcovecchio, M. L., Pamela, C., Cooper, J. D., Ferreira, R. C., Howson, J. M. M., Jolley, J., Nutland, S. L., Stevens, H. E., Walker, N. M., et al. (2013) · Diabetologia · doi:10.1007/s00125-013-3113-8 · Cited by 38
Differentiation, expansion, and homeostasis of autoreactive T cells in type 1 diabetes mellitus
Monti, P., Heninger, A., & Bonifacio, E. E. (2009) · Current Diabetes Reports · doi:10.1007/s11892-009-0020-y · Cited by 39
Ramagopalan, S. V., & Ebers, G. C. (2009) · Neurology · doi:10.1212/01.wnl.0000341941.24967.e6 · Cited by 39
The efficacy and safety of daclizumab and its potential role in the treatment of multiple sclerosis
Milo, R. (2014) · Therapeutic Advances in Neurological Disorders · doi:10.1177/1756285613504021 · Cited by 38
Immune Regulatory Functions of Macrophages and Microglia in Central Nervous System Diseases
Poppell, M., Hammel, G., & Ren, Y. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24065925 · Cited by 39
HLA-DRB1*1501 and Spinal Cord Magnetic Resonance Imaging Lesions in Multiple Sclerosis
Sombekke, M. H., Lukas, C., Crusius, J. B. A., Tejedor, D., Killestein, J., Arteta, D., Martínez, A., Uitdehaag, B. M. J., Knol, D. L., Peña, A. S., et al. (2009) · Archives of Neurology · doi:10.1001/archneurol.2009.278 · Cited by 37
Fingolimod alters the transcriptome profile of circulating CD4+ cells in multiple sclerosis
Friess, J., Hecker, M., Roch, L., Koczan, D., Fitzner, B., Angerer, I. C., Schröder, I., Flechtner, K., Thiesen, H., Winkelmann, A., et al. (2017) · Scientific Reports · doi:10.1038/srep42087 · Cited by 41
Environmental Influencers, MicroRNA, and Multiple Sclerosis
Mohammed, E. M. A. (2020) · Journal of Central Nervous System Disease · doi:10.1177/1179573519894955 · Cited by 39
Genetically determined myocarditis: clinical presentation and immunological characteristics
Caforio, A. L. P., & Iliceto, S. (2008) · Current Opinion in Cardiology · doi:10.1097/hco.0b013e3282fbf572 · Cited by 37
The dual nature of neuroinflammation in networked brain
Müller, L., Benedetto, S. D., & Müller, V. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1659947 · Cited by 43
Polymorphisms in the IL2RA and IL2RB Genes in Inflammatory Bowel Disease Risk
Bouzid, D., Amouri, A., Fourati, H., Marques, I., Abida, O., Tahri, N., Penha‐Gonçalves, C., & Masmoudi, H. (2013) · Genetic Testing and Molecular Biomarkers · doi:10.1089/gtmb.2013.0291 · Cited by 37
Epistasis and immunity: the role of genetic interactions in autoimmune diseases
Rose, A. M., & Bell, L. C. K. (2012) · Immunology · doi:10.1111/j.1365-2567.2012.03623.x · Cited by 40
Genetics of multiple sclerosis
Hoppenbrouwers, I. A., & Hintzen, R. Q. (2010) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2010.09.017 · Cited by 39
Genetic variants in IL2RA and IL7R affect multiple sclerosis disease risk and progression
Traboulsee, A. L., Bernales, C. Q., Ross, J. P., Lee, J. D., Sadovnick, A. D., & Vilariño‐Güell, C. (2014) · Neurogenetics · doi:10.1007/s10048-014-0403-3 · Cited by 41
ALCAM and CD6 — multiple sclerosis risk factors
Wagner, M., Bilińska, M. M., Pokryszko‐Dragan, A., Sobczyński, M., Cyrul, M., Kuśnierczyk, P., & Jasek, M. (2014) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2014.08.621 · Cited by 37
Petersen, E. R., Søndergaard, H. B., Laursen, J. H., Olsson, A., Börnsen, L. S., Sørensen, P. S., Sellebjerg, F. T., & Oturai, A. B. (2018) · Multiple Sclerosis Journal · doi:10.1177/1352458518791753 · Cited by 37
Interpreting Non-coding Genetic Variation in Multiple Sclerosis Genome-Wide Associated Regions
Paraboschi, E. M., Cardamone, G., Soldà, G., Duga, S., & Asselta, R. (2018) · Frontiers in Genetics · doi:10.3389/fgene.2018.00647 · Cited by 37
Izadi, M., Tahmasebi, S., Pustokhina, I., Yumashev, A. V., Lakzaei, T., Alvanegh, A. G., Roshangar, L., Dadashpour, M., Yousefi, M., & Ahmadi, M. (2020) · Multiple Sclerosis and Related Disorders · doi:10.1016/j.msard.2020.102466 · Cited by 37
Call, M. J., Xing, X., Cuny, G. D., Seth, N. P., Altmann, D. M., Fugger, L. H., Krogsgaard, M., Stein, R. L., & Wucherpfennig, K. W. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.0803464 · Cited by 37
‘Drug Reactions, Enzymes, and Biochemical Genetics‘: 50 years Later
Gurwitz, D., & Motulsky, A. G. (2007) · Pharmacogenomics · doi:10.2217/14622416.8.11.1479 · Cited by 37
Multiple sclerosis is prominent in the Gulf states: Review
Mohammed, E. M. A. (2016) · Pathogenesis · doi:10.1016/j.pathog.2016.04.001 · Cited by 38
Epstein-Barr Virus and Multiple Sclerosis
Lünemann, J. D., & Münz, C. (2007) · Current Neurology and Neuroscience Reports · doi:10.1007/s11910-007-0038-y · Cited by 36
Chemotherapeutics in the treatment of multiple sclerosis
Kieseier, B. C., & Jeffery, D. (2010) · Therapeutic Advances in Neurological Disorders · doi:10.1177/1756285610379885 · Cited by 36
Tracing environmental markers of autoimmunity: introducing the infectome
Bogdanos, D. P., Smyk, D. S., Invernizzi, P., Rigopoulou, E. I., Blank, M., Sakkas, L. I., Pouria, S., & Shoenfeld, Y. (2013) · Immunologic Research · doi:10.1007/s12026-013-8399-6 · Cited by 38
Association of SNPs of CD40 Gene with Multiple Sclerosis in Russians
Sokolova, E. А., Malkova, N. A., Korobko, D. S., Rozhdestvenskiĭ, A. S., Kakulya, A. V., Ханох, Е. В., Ra, D., Платонов, Ф. А., Popova, T., Геннадьевна, А. Е., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0061032 · Cited by 36
Aung, L. L., Fitzgerald-Bocarsly, P. A., Dhib-Jalbut, S. S., & Balashov, K. E. (2010) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2010.06.008 · Cited by 38
Li, Y., Ni, R., Song, W., Shao, W., Shrestha, S., Ahmad, S., Cunningham, C. K., Flynn, P. M., Kapogiannis, B. G., Wilson, C. M., et al. (2009) · Human Genetics · doi:10.1007/s00439-009-0720-z · Cited by 36
The major cause of multiple sclerosis is environmental: genetics has a minor role - Yes
Taylor, B. V. (2011) · Multiple Sclerosis Journal · doi:10.1177/1352458511421105 · Cited by 36
Autoimmunity risk alleles in costimulation pathways
Maier, L. M., & Hafler, D. A. (2009) · Immunological Reviews · doi:10.1111/j.1600-065x.2009.00777.x · Cited by 36
Metadata
- Authors
- The International Multiple Sclerosis Genetics Consortium
- Corresponding author
- The International Multiple Sclerosis Genetics Consortium
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 2007-08-30
- Volume
- 357
- Issue
- 9
- Pages
- 851-862
- ISSN
- 0028-4793 (ISSN-L)
- 1533-4406
- OpenAlex
- W2164392039
- Cited by
- 1,746
- References
- 64
- Citations by year
- 2026: 26 · 2025: 38 · 2024: 40 · 2023: 32 · 2022: 55 · 2021: 49 · 2020: 57 · 2019: 53 · 2018: 66 · 2017: 74 · 2016: 75 · 2015: 97 · 2014: 109 · 2013: 112 · 2012: 145
- FWCI
- 132.85
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- New England Journal of Medicine (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Wellcome Trust (076113)
- National Institutes of Health (6u54rr020278-06)
- National Institute of Allergy and Infectious Diseases (U19AI067152, AI-067152, P01AI039671)
- National Institute of Neurological Disorders and Stroke (NS26799, NS032830, NS049477, NS2427, R01NS032830, R01NS026799, R01NS049477)
- National Center for Research Resources (U54-RR020278-1)
- Topics
- Health Sciences › Medicine › Clinical Neurology › Multiple Sclerosis Research Studies
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genetic Associations and Epidemiology
- Life Sciences › Immunology and Microbiology › Immunology › Psoriasis: Treatment and Pathogenesis
- Keywords
- multiple sclerosis, genetic susceptibility, single nucleotide polymorphisms, family trios, transmission disequilibrium test, IL2RA, CD127, HLA-DRA, IL-2 receptor alpha, HLA locus, heritability
- MeSH terms
- Adolescent, Adult, Aged, Alleles, Female, HLA-DR Antigens, Humans, Male, Middle Aged, Multiple Sclerosis, Mutation, Risk Factors, Linkage Disequilibrium, Genome, Human, Genetic Predisposition to Disease, Oligonucleotide Array Sequence Analysis, Polymorphism, Single Nucleotide, Interleukin-2 Receptor alpha Subunit, Interleukin-7 Receptor alpha Subunit, HLA-DR alpha-Chains
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review